{"id":143668,"date":"2024-09-28T07:29:04","date_gmt":"2024-09-28T07:29:04","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/09\/28\/regeneron-sanofi-get-fda-ok-for-dupixent-to-treat-copd\/"},"modified":"2024-09-28T07:29:04","modified_gmt":"2024-09-28T07:29:04","slug":"regeneron-sanofi-get-fda-ok-for-dupixent-to-treat-copd","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/09\/28\/regeneron-sanofi-get-fda-ok-for-dupixent-to-treat-copd\/","title":{"rendered":"Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD"},"content":{"rendered":"<div style=\"text-align:center\"><img loading=\"lazy\" decoding=\"async\" width=\"553\" height=\"369\" src=\"https:\/\/i2.wp.com\/images.wsj.net\/im-17862083\/medium?resize=553,369&amp;ssl=1\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD\" title=\"Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD\" \/><\/div>\n<p>Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.wsj.com\/articles\/regeneron-sanofi-get-fda-ok-for-dupixent-to-treat-copd-e5c57989?mod=pls_whats_news_us_business_f\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease. Source link<\/p>\n","protected":false},"author":2,"featured_media":143669,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/images.wsj.net\/im-17862083\/medium","fifu_image_alt":"","footnotes":""},"categories":[604],"tags":[114316,114315,15341,52759,16451,4423],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/143668"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=143668"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/143668\/revisions"}],"predecessor-version":[{"id":143670,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/143668\/revisions\/143670"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/143669"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=143668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=143668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=143668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}